LEXICON PHARMACEUTICALS, INC. Public Float
LEXICON PHARMACEUTICALS, INC. (LXRX) had Public Float of $170.00 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $170.00M.
- 2024-06-30: Entity Public Float $297.10M.
- 2023-06-30: Entity Public Float $273.70M.
- 2022-06-30: Entity Public Float $134.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $170.00M 10-K · filed 2026-03-05 |
| 2024-06-30 | $297.10M 10-K · filed 2025-03-07 |
| 2023-06-30 | $273.70M 10-K · filed 2024-03-25 |
| 2022-06-30 | $134.40M 10-K · filed 2023-03-03 |
| 2021-06-30 | $309.40M 10-K · filed 2022-03-10 |
| 2020-06-30 | $82.00M 10-K · filed 2021-03-12 |
| 2019-06-30 | $259.50M 10-K · filed 2020-03-12 |
| 2018-06-30 | $491.50M 10-K · filed 2019-03-15 |
| 2017-06-30 | $715.30M 10-K · filed 2018-03-01 |
| 2016-06-30 | $599.90M 10-K · filed 2017-03-06 |
| 2015-06-30 | $335.00M 10-K · filed 2016-03-11 |
| 2014-06-30 | $368.00M 10-K · filed 2015-03-12 |
| 2013-06-30 | $493.40M 10-K · filed 2014-03-07 |
| 2012-06-30 | $446.30M 10-K · filed 2013-03-11 |
| 2011-06-30 | $229.70M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |